A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease

NCT07419828 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1978

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: HRS-1780 tablets
DRUG: Placebo

Sponsor

Shandong Suncadia Medicine Co., Ltd.